Overall, despite that a high IF1 level confers to breast, colon and lung cancer cells a more glycolytic phenotype, it restrains tumor growth and metastatic disease by repressing OXPHOS and thus underpinning the better prognosis of the cancer patients that bear tumors with high expression levels of IF1 (Figure 5). This evidence concerns the gene ATP5IF1 and lung carcinoma.